ARCHIVES

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Congress gives FDA authority to require pediatric clinical trials.

November 28, 2003

New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions

July 10, 1987

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001